Anti Tissue Transglutaminase IgG (TTG) at Ayzal Lab

Anti Tissue Transglutaminase IgG (TTG) at Ayzal Lab

The Anti Tissue Transglutaminase IgG (TTG) test is a highly specialized serological laboratory investigation used primarily in the diagnostic evaluation of gluten-sensitive enteropathies, most notably celiac disease. Ayzal Lab, located in Lahore, Pakistan, offers this advanced immunological assay to assist clinicians in accurately identifying autoimmune responses triggered by dietary gluten. Tissue transglutaminase is an intracellular enzyme that plays a critical role in tissue repair and fiber cross-linking. When individuals with a genetic predisposition ingest gluten—a protein found in wheat, barley, and rye—their immune system recognizes tissue transglutaminase as an antigen, leading to the production of autoantibodies. While the IgA isotype of TTG is the primary screening tool, the IgG isotype is clinically indispensable, particularly for patients with selective IgA deficiency, which is highly prevalent among individuals with celiac disease.

At Ayzal Lab, the Anti Tissue Transglutaminase IgG test is performed using state-of-the-art enzyme-linked immunosorbent assay (ELISA) or chemiluminescent immunoassay (CLIA) technologies. These advanced methodologies ensure high analytical sensitivity and specificity, minimizing the risk of false-positive or false-negative results. The test evaluates the concentration of IgG-class autoantibodies directed against the tissue transglutaminase enzyme in the blood. This evaluation is crucial for diagnosing celiac disease, monitoring adherence to a gluten-free diet, and assessing the resolution of autoimmune activity over time. By providing precise quantitative measurements, Ayzal Lab enables gastroenterologists, pediatricians, and general physicians to make informed clinical decisions, initiate appropriate dietary interventions, and prevent long-term complications associated with untreated malabsorption syndromes.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the clinical utility and diagnostic accuracy of the Anti Tissue Transglutaminase IgG (TTG) test at Ayzal Lab, patients must adhere to specific preparation guidelines:

• Maintain a Gluten-Containing Diet: It is clinically vital that the patient continues to consume a normal, gluten-containing diet (including bread, pasta, and cereals) for at least several weeks leading up to the blood draw. Initiating a gluten-free diet prior to testing can lead to a rapid decline in antibody levels, resulting in a false-negative result that masks active celiac disease.
• Fasting Requirements: Routine fasting is generally not mandatory for this specific immunological assay. However, patients are advised to consult their referring physician or Ayzal Lab staff, as fasting may be required if other concurrent blood tests, such as lipid profiles or fasting blood glucose, are scheduled for the same visit.
• Medication Disclosure: Patients must inform the laboratory staff and their healthcare provider of all current medications, particularly immunosuppressants, corticosteroids, or chemotherapy drugs, as these agents can suppress antibody production and alter test results.
• Hydration: Adequate hydration is highly recommended prior to the procedure. Drinking sufficient water makes venipuncture easier by expanding blood volume and improving vein visibility.

During the Procedure

The Anti Tissue Transglutaminase IgG test is a standard outpatient laboratory procedure involving a simple venipuncture. Upon arrival at Ayzal Lab, the patient is seated comfortably in a blood collection chair. The phlebotomist verifies the patient’s identity and explains the procedure. The clinical steps are executed with strict adherence to safety and hygiene protocols:

• Site Selection and Preparation: The phlebotomist examines the patient’s arm, typically selecting a prominent vein in the antecubital fossa (the crook of the elbow). The chosen site is thoroughly sanitized with an antiseptic swab containing isopropyl alcohol and allowed to air dry to prevent hemolysis of the blood sample.
• Tourniquet Application: A sterile tourniquet is applied a few inches above the selected site to restrict venous blood flow, causing the veins to swell and become more accessible.
• Venipuncture: Using a sterile, single-use, fine-gauge needle attached to a vacuum collection tube, the phlebotomist gently inserts the needle into the vein. A small volume of blood (typically 3 to 5 milliliters) is drawn into a serum separator tube (SST) or a plain red-top tube.
• Needle Removal and Hemostasis: Once the sample is collected, the tourniquet is released, and the needle is smoothly withdrawn. Immediate pressure is applied to the puncture site with a sterile cotton ball or gauze pad to promote hemostasis and prevent hematoma formation. A small adhesive bandage is then applied.
• Sample Processing: The collected blood sample is labeled immediately at the patient’s side with unique identifiers. It is then transferred to the processing area of Ayzal Lab, where it undergoes centrifugation to separate the serum from the cellular components. The serum is then analyzed using advanced immunological platforms. The entire collection process takes less than five minutes and involves minimal discomfort, comparable to a brief pinprick.

When is an Anti Tissue Transglutaminase IgG (TTG) Test Performed?

Diagnosis of Celiac Disease in IgA-Deficient Patients

Celiac disease is an autoimmune enteropathy characterized by mucosal inflammation, villous atrophy, and crypt hyperplasia in the small intestine upon gluten ingestion. While the Anti-TTG IgA test is the gold standard for screening, approximately 2% to 3% of patients with celiac disease suffer from selective IgA deficiency—a condition that causes false-negative IgA results. In these clinical scenarios, physicians request the Anti Tissue Transglutaminase IgG test. This IgG-based assay bypasses the IgA deficiency, providing an accurate diagnostic pathway to identify gluten-induced autoimmunity and prevent misdiagnosis in vulnerable patient populations.

Evaluation of Unexplained Gastrointestinal Symptoms

Gastrointestinal distress is a primary clinical presentation of gluten sensitivity and celiac disease. Physicians frequently order the Anti-TTG IgG test when patients present with chronic, unexplained diarrhea, persistent abdominal pain, bloating, flatulence, nausea, vomiting, or altered bowel habits. Because these symptoms overlap significantly with irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and food intolerances, the quantitative antibody test at Ayzal Lab serves as a critical diagnostic tool to differentiate autoimmune gluten sensitivity from other functional or structural gastrointestinal disorders.

Investigation of Malabsorption and Nutritional Deficiencies

Chronic inflammation of the small intestinal mucosa impairs the body’s ability to absorb essential nutrients, leading to systemic clinical manifestations. The Anti-TTG IgG test is indicated for patients presenting with unexplained weight loss, chronic fatigue, failure to thrive in pediatric patients, short stature, and severe nutritional deficiencies. These deficiencies often manifest as iron-deficiency anemia refractory to oral iron supplementation, vitamin D deficiency, osteopenia, osteoporosis, or peripheral neuropathy. Identifying elevated TTG IgG antibodies helps confirm that intestinal malabsorption driven by celiac disease is the underlying cause of these systemic deficiencies.

Assessment of Extraintestinal Autoimmune Manifestations

Celiac disease frequently presents with extraintestinal symptoms that may not immediately suggest a gastrointestinal origin. Clinicians request the Anti-TTG IgG test when patients exhibit dermatitis herpetiformis (an intensely itchy, blistering skin rash linked directly to gluten sensitivity), recurrent aphthous stomatitis (mouth ulcers), unexplained elevation of liver transaminases (transaminitis), joint pain, or unexplained neurological symptoms such as ataxia or migraines. Detecting these autoantibodies helps link these diverse systemic manifestations to gluten-induced autoimmunity, guiding appropriate therapeutic strategies.

Monitoring Dietary Compliance and Disease Resolution

For patients with a confirmed diagnosis of celiac disease, the Anti Tissue Transglutaminase IgG test is utilized as a non-invasive monitoring tool. After initiating a strict, lifelong gluten-free diet, antibody levels in the blood should gradually decline. Physicians at Ayzal Lab recommend periodic testing of TTG IgG to monitor dietary compliance, assess the resolution of the autoimmune response, and ensure that the intestinal mucosa is healing. A persistent elevation or a sudden rise in antibody levels suggests ongoing, accidental, or deliberate gluten exposure, necessitating further nutritional counseling or clinical evaluation.

What Does an Anti Tissue Transglutaminase IgG (TTG) Test Detect?

The Anti Tissue Transglutaminase IgG test at Ayzal Lab is designed to detect and quantify specific immunological markers and clinical states associated with gluten sensitivity:

• Elevated IgG Autoantibodies: Detects high concentrations of IgG-class antibodies directed against tissue transglutaminase, indicating an active autoimmune response.
• Selective IgA Deficiency Co-existence: Identifies potential celiac disease in patients who lack the ability to produce IgA antibodies.
• Gluten-Induced Enteropathy: Strongly correlates with the presence of small intestinal mucosal damage, including villous atrophy and crypt hyperplasia.
• Dietary Non-Compliance: Detects ongoing exposure to gluten in patients who are supposed to be adhering to a strict gluten-free diet.
• Refractory Celiac Disease: Helps identify patients who do not respond to a gluten-free diet, characterized by persistently high antibody titers.
• Autoimmune Susceptibility: Points toward an underlying genetic predisposition (associated with HLA-DQ2 and HLA-DQ8 genotypes) linked to celiac disease.
• Silent Celiac Disease: Detects active autoimmune processes in asymptomatic individuals who may have a family history of the disease.
• Potential for Dermatitis Herpetiformis: Correlates with the cutaneous manifestations of gluten sensitivity.
• Secondary Malabsorption Markers: Explains the underlying cause of low serum iron, ferritin, calcium, and vitamin D levels.
• Assay Specificity: Differentiates celiac-related autoimmunity from non-celiac gluten sensitivity, which does not typically elevate TTG antibodies.

Turnaround Time and Report Access at Ayzal Lab

Ayzal Lab is committed to providing rapid, accurate, and highly reliable diagnostic reporting. The turnaround time for the Anti Tissue Transglutaminase IgG (TTG) test is typically within 24 to 48 hours from the time of sample collection. Once the analysis is completed by our experienced laboratory technologists and verified by a consultant pathologist, patients are notified immediately via SMS. Reports can be accessed online through the official Ayzal Lab web portal, allowing patients and referring physicians to view, download, and print the results from the comfort of their homes. Physical copies of the report are also available for collection at the laboratory’s main reception desk in Lahore.

Anti Tissue Transglutaminase IgG (TTG) Findings Overview

The following table outlines the clinical parameters evaluated during the Anti-TTG IgG test, along with normal and possible abnormal findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Anti-TTG IgG Antibody Level	Negative (< 6.0 U/mL)	Positive (≥ 6.0 U/mL), indicating active celiac disease or gluten sensitivity.
Total Serum IgA Level	Within normal reference range for age	Low or undetectable IgA, indicating selective IgA deficiency.
Intestinal Mucosal Integrity	Normal villous architecture (inferred from negative serology)	Severe villous atrophy, crypt hyperplasia, and intraepithelial lymphocytosis.
Nutritional Absorption Status	Normal absorption of iron, calcium, and fat-soluble vitamins	Malabsorption leading to anemia, osteopenia, and vitamin deficiencies.
Clinical Symptom Correlation	Absence of gastrointestinal or extraintestinal symptoms	Chronic diarrhea, abdominal pain, bloating, weight loss, or dermatitis herpetiformis.
Dietary Response Monitoring	Antibody levels returning to normal on a gluten-free diet	Persistently elevated antibody levels, indicating ongoing gluten exposure.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Ayzal Lab for Anti Tissue Transglutaminase IgG (TTG)?

• Experienced Healthcare Professionals: Our clinical team consists of highly qualified pathologists, laboratory technologists, and phlebotomists dedicated to diagnostic excellence.
• Patient-Focused Care: We prioritize patient comfort, safety, and confidentiality throughout the entire testing process.
• Quality Diagnostic Services: Ayzal Lab adheres to stringent internal and external quality control measures to ensure the highest accuracy of test results.
• Professional Reporting: Our reports are comprehensive, easy to understand, and verified by expert consultant pathologists.
• Modern Diagnostic Approach: We utilize advanced immunological platforms, including ELISA and CLIA, for precise antibody quantification.
• Comfortable Environment: Our state-of-the-art collection centers in Lahore are designed to provide a stress-free and hygienic experience.
• Convenient Location: Easily accessible facilities across Lahore make it simple for patients to visit for blood collection.
• Commitment to Accurate Diagnosis: We are dedicated to providing reliable results that empower clinicians to deliver optimal patient care.